Candida auris invasive infections during a COVID-19 case surge

Blake M. Hanson, An Q. Dinh, Truc T. Tran, Sebastian Arenas, Darryl Pronty, Hayley B. Gershengorn, Tanira Ferreira, Cesar A. Arias, Bhavarth S. Shukla

Research output: Contribution to journalArticlepeer-review

14 Scopus citations


Clinical cases of C. auris noted during a COVID-19 surge led to an epidemiological, clinical, and genomic investigation. Evaluation identified a close genetic relationship but inconclusive epidemiologic link between all cases. Prolonged hospitalization due to critical illness from COVID-19 and use of antimicrobials may have contributed to clinical infections.

Original languageEnglish (US)
Article numbere01146-21
Pages (from-to)e0114621
JournalAntimicrobial Agents and Chemotherapy
Issue number10
StatePublished - Sep 17 2021


  • COVID-19
  • Candida auris
  • Outbreak investigation
  • Whole-genome sequencing
  • SARS-CoV-2
  • Candidiasis, Invasive/drug therapy
  • Humans
  • Antifungal Agents/therapeutic use
  • Candida/genetics

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Infectious Diseases
  • Pharmacology


Dive into the research topics of 'Candida auris invasive infections during a COVID-19 case surge'. Together they form a unique fingerprint.

Cite this